Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) has been assigned an average rating of “Hold” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $5.1875.
A number of research firms have issued reports on ASPN. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday. TD Cowen cut their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Barclays raised their target price on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research note on Monday, May 11th. Finally, Roth Mkm reiterated a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a research note on Friday, May 8th.
View Our Latest Stock Analysis on Aspen Aerogels
Institutional Investors Weigh In On Aspen Aerogels
Aspen Aerogels Stock Performance
Aspen Aerogels stock opened at $5.61 on Friday. The company has a market cap of $465.19 million, a PE ratio of -4.13 and a beta of 2.83. The company has a fifty day moving average price of $3.73 and a two-hundred day moving average price of $3.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 3.29. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The business’s revenue for the quarter was down 51.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.06) EPS. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Research analysts expect that Aspen Aerogels will post -0.8 earnings per share for the current year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Read More
- Five stocks we like better than Aspen Aerogels
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
